Medtronic PLC
NYSE:MDT
Balance Sheet
Balance Sheet Decomposition
Medtronic PLC
Current Assets | 22.5B |
Cash & Short-Term Investments | 8.3B |
Receivables | 6B |
Other Current Assets | 8.2B |
Non-Current Assets | 68.3B |
Long-Term Investments | 1.6B |
PP&E | 5.8B |
Intangibles | 54.9B |
Other Non-Current Assets | 6B |
Current Liabilities | 9.8B |
Accounts Payable | 2B |
Accrued Liabilities | 5.3B |
Short-Term Debt | 1B |
Other Current Liabilities | 1.5B |
Non-Current Liabilities | 29.3B |
Long-Term Debt | 24.2B |
Other Non-Current Liabilities | 5.1B |
Balance Sheet
Medtronic PLC
Apr-2014 | Apr-2015 | Apr-2016 | Apr-2017 | Apr-2018 | Apr-2019 | Apr-2020 | Apr-2021 | Apr-2022 | Apr-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
1 403
|
4 843
|
2 876
|
4 967
|
3 669
|
4 393
|
4 140
|
3 593
|
3 714
|
1 543
|
|
Cash Equivalents |
1 403
|
4 843
|
2 876
|
4 967
|
3 669
|
4 393
|
4 140
|
3 593
|
3 714
|
1 543
|
|
Short-Term Investments |
12 838
|
14 637
|
9 758
|
8 741
|
7 558
|
5 455
|
6 808
|
7 224
|
6 859
|
6 416
|
|
Total Receivables |
3 811
|
5 112
|
5 562
|
5 591
|
5 987
|
6 222
|
4 645
|
5 462
|
5 551
|
5 998
|
|
Accounts Receivables |
3 811
|
5 112
|
5 562
|
5 591
|
5 987
|
6 222
|
4 645
|
5 462
|
5 551
|
5 998
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
1 725
|
3 463
|
3 473
|
3 338
|
3 579
|
3 753
|
4 229
|
4 313
|
4 616
|
5 293
|
|
Other Current Assets |
1 433
|
2 789
|
1 931
|
2 236
|
2 187
|
2 144
|
2 209
|
1 956
|
2 319
|
2 425
|
|
Total Current Assets |
21 210
|
30 844
|
23 600
|
24 873
|
22 980
|
21 967
|
22 031
|
22 548
|
23 059
|
21 675
|
|
PP&E Net |
2 392
|
4 699
|
4 841
|
4 361
|
4 604
|
4 675
|
5 755
|
6 219
|
6 267
|
6 610
|
|
PP&E Gross |
2 392
|
4 699
|
4 841
|
4 361
|
4 604
|
4 675
|
5 755
|
6 219
|
6 267
|
6 610
|
|
Accumulated Depreciation |
4 047
|
4 164
|
4 873
|
5 330
|
5 655
|
6 245
|
6 816
|
7 479
|
7 952
|
8 493
|
|
Intangible Assets |
2 286
|
28 101
|
26 899
|
23 407
|
21 723
|
20 560
|
19 063
|
17 740
|
15 595
|
14 844
|
|
Goodwill |
10 593
|
40 530
|
41 500
|
38 515
|
39 543
|
39 959
|
39 841
|
41 961
|
40 502
|
41 425
|
|
Long-Term Investments |
0
|
0
|
0
|
692
|
515
|
372
|
480
|
687
|
881
|
1 607
|
|
Other Long-Term Assets |
1 462
|
2 511
|
2 804
|
8 009
|
2 028
|
2 161
|
3 519
|
3 928
|
4 677
|
4 787
|
|
Other Assets |
10 593
|
40 530
|
41 500
|
38 515
|
39 543
|
39 959
|
39 841
|
41 961
|
40 502
|
41 425
|
|
Total Assets |
37 943
N/A
|
106 685
+181%
|
99 644
-7%
|
99 857
+0%
|
91 393
-8%
|
89 694
-2%
|
90 689
+1%
|
93 083
+3%
|
90 981
-2%
|
90 948
0%
|
|
Liabilities | |||||||||||
Accounts Payable |
742
|
1 610
|
1 709
|
1 555
|
1 628
|
1 953
|
1 996
|
2 106
|
2 276
|
2 662
|
|
Accrued Liabilities |
2 935
|
4 033
|
3 784
|
4 443
|
5 232
|
4 885
|
4 839
|
5 681
|
5 367
|
5 216
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
1 601
|
2 424
|
993
|
7 520
|
2 058
|
838
|
2 776
|
11
|
3 742
|
20
|
|
Other Current Liabilities |
281
|
1 106
|
679
|
746
|
1 166
|
796
|
755
|
711
|
1 009
|
1 153
|
|
Total Current Liabilities |
5 559
|
9 173
|
7 165
|
14 264
|
10 084
|
8 472
|
10 366
|
8 509
|
12 394
|
9 051
|
|
Long-Term Debt |
10 315
|
33 752
|
30 109
|
25 921
|
23 699
|
24 486
|
22 021
|
26 378
|
20 372
|
24 344
|
|
Deferred Income Tax |
386
|
4 700
|
3 729
|
2 978
|
1 423
|
1 278
|
1 174
|
1 028
|
884
|
708
|
|
Minority Interest |
0
|
0
|
0
|
122
|
102
|
121
|
135
|
174
|
171
|
182
|
|
Other Liabilities |
2 240
|
5 830
|
6 578
|
6 364
|
5 365
|
5 246
|
6 256
|
5 566
|
4 609
|
5 180
|
|
Total Liabilities |
18 500
N/A
|
53 455
+189%
|
47 581
-11%
|
49 649
+4%
|
40 673
-18%
|
39 603
-3%
|
39 952
+1%
|
41 655
+4%
|
38 430
-8%
|
39 465
+3%
|
|
Equity | |||||||||||
Common Stock |
100
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
19 940
|
54 414
|
21 704
|
23 270
|
24 379
|
26 270
|
28 132
|
28 594
|
30 250
|
30 392
|
|
Additional Paid In Capital |
0
|
0
|
32 227
|
29 551
|
28 127
|
26 532
|
26 165
|
26 319
|
24 566
|
24 590
|
|
Unrealized Security Profit/Loss |
6
|
14
|
107
|
69
|
194
|
45
|
0
|
92
|
209
|
258
|
|
Other Equity |
591
|
1 198
|
1 761
|
2 544
|
1 592
|
2 666
|
3 560
|
3 577
|
2 056
|
3 241
|
|
Total Equity |
19 443
N/A
|
53 230
+174%
|
52 063
-2%
|
50 208
-4%
|
50 720
+1%
|
50 091
-1%
|
50 737
+1%
|
51 428
+1%
|
52 551
+2%
|
51 483
-2%
|
|
Total Liabilities & Equity |
37 943
N/A
|
106 685
+181%
|
99 644
-7%
|
99 857
+0%
|
91 393
-8%
|
89 694
-2%
|
90 689
+1%
|
93 083
+3%
|
90 981
-2%
|
90 948
0%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
999
|
1 422
|
1 399
|
1 369
|
1 354
|
1 341
|
1 341
|
1 345
|
1 331
|
1 331
|